A carregar...

Pharmacogenetic analysis of opioid dependence treatment dose and dropout rate

BACKGROUND: Currently, no pharmacogenetic tests for selecting an opioid dependence pharmacotherapy have been approved by the FDA. OBJECTIVES: Determine the effects of variants in 11 genes on dropout rate and dose in patients receiving methadone or buprenorphine/naloxone (ClinicalTrials.gov Identifie...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Drug Alcohol Abuse
Main Authors: Crist, Richard C., Li, James, Doyle, Glenn A., Gilbert, Alex, Dechairo, Bryan M., Berrettini, Wade H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5940523/
https://ncbi.nlm.nih.gov/pubmed/29333880
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/00952990.2017.1420795
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!